| Income Statement | 2024-12-31 | |||
|---|---|---|---|---|
| Revenue - related party | 41 | |||
| Research and development | 36,152 | |||
| General and administrative | 20,063 | |||
| Total operating expenses | 56,215 | |||
| Loss from operations | -56,174 | |||
| Interest income | 11 | |||
| Foreign currency exchange loss | -4 | |||
| Gain (loss) on common stock warrant liabilities | -73 | |||
| Total other income (loss) | -66 | |||
| Net loss | -56,240 | |||
| Basic eps | -1.42 | |||
| Diluted eps | -1.42 | |||
| Basic average shares | 39,674,444 | |||
| Diluted average shares | 39,674,444 | |||
null (CKPT)
null (CKPT)